Impact of tobacco control interventions on smoking initiation, cessation, and prevalence: a systematic review.

Tobacco control policy smoking cessation smoking initiation smoking prevalence

Journal

Journal of thoracic disease
ISSN: 2072-1439
Titre abrégé: J Thorac Dis
Pays: China
ID NLM: 101533916

Informations de publication

Date de publication:
Jul 2020
Historique:
entrez: 18 8 2020
pubmed: 18 8 2020
medline: 18 8 2020
Statut: ppublish

Résumé

This article investigates the effects of tobacco control policies on smoking initiation, cessation and prevalence by examining the papers published in the last 5 years. Twenty-one articles have been selected by two authors and sorted by four types of tobacco control: tobacco prices, anti-smoking campaigns for young people, mass media intervention and public smoking bans. Price/tax increase has deterrent effect on smoking initiation but does not promote smoking cessation; intervention on young people could reduce the smoking initiation if carried out at an early age and if acted on social skills and with peer-led approach, as opposed to restraining measures which hare generally easily circumvented by young people. The mass media campaigns showed positive effect on attempts to quit among smokers if carried forward over time and by involving multiple communication channels (TV, internet, radio). The bans in public have little effect on smoking cessation but could improve the overall well-being of non-smokers. Heterogeneous results have been described by different studies probably because of different research methodologies, cultural aspects and the really effective implementation of the rules for each country. In conclusion, comprehensive tobacco control interventions to reduce smoking prevalence and modify the smoking behavior are recommended. Moreover, the use of e-cigarettes and heat-not-burn (HnB) products, as possible helping tool for smoke cessation, currently remains controversial.

Identifiants

pubmed: 32802466
doi: 10.21037/jtd.2020.02.23
pii: jtd-12-07-3844
pmc: PMC7399441
doi:

Types de publication

Journal Article Review

Langues

eng

Pagination

3844-3856

Informations de copyright

2020 Journal of Thoracic Disease. All rights reserved.

Déclaration de conflit d'intérêts

Conflicts of Interest: All authors have completed the ICMJE uniform disclosure form (available at http://dx.doi.org/10.21037/jtd.2020.02.23). The series “Improving Outcomes in Lung Cancer Through Early Diagnosis and Smoking Cessation” was commissioned by the editorial office without any funding or sponsorship. The authors have no other conflicts of interest to declare.

Références

J Health Econ. 2011 May;30(3):560-7
pubmed: 21477875
Cochrane Database Syst Rev. 2006 Jul 19;(3):CD001293
pubmed: 16855966
Addiction. 2018 Nov;113(11):2099-2106
pubmed: 29920842
BMJ Open. 2019 Mar 13;9(3):e026642
pubmed: 30872554
N Engl J Med. 2018 Jun 14;378(24):2302-2310
pubmed: 29791259
Epidemiol Prev. 2018 Sep-Dec;42(5-6):351-355
pubmed: 30370737
Cochrane Database Syst Rev. 2016 Sep 14;9:CD010216
pubmed: 27622384
N Engl J Med. 2019 May 16;380(20):1973-1974
pubmed: 31091383
Lancet Public Health. 2019 Dec;4(12):e618-e627
pubmed: 31759897
Health Econ. 2015 Feb;24(2):175-92
pubmed: 24677756
Otolaryngol Head Neck Surg. 2014 Sep;151(3):381-93
pubmed: 24898072
Prev Med. 2016 Dec;93:14-20
pubmed: 27612572
Addict Behav. 2015 Jun;45:104-9
pubmed: 25658771
Lancet. 2013 Nov 16;382(9905):1629-37
pubmed: 24029165
Circulation. 2014 May 13;129(19):1972-86
pubmed: 24821826
Addict Behav. 2019 Apr;91:227-233
pubmed: 30224155
Tob Control. 2020 Jan;29(1):49-54
pubmed: 30498008
Nicotine Tob Res. 2019 Aug 19;21(9):1285-1288
pubmed: 30476301
JAMA Intern Med. 2017 Jul 1;177(7):1050-1052
pubmed: 28531246
Nicotine Tob Res. 2015 Nov;17(11):1397-400
pubmed: 25586775
PLoS One. 2013 Jun 24;8(6):e66317
pubmed: 23826093
Tob Control. 2018 Nov;27(Suppl 1):s37-s38
pubmed: 30242043
J Clin Pharm Ther. 2019 Aug;44(4):650-655
pubmed: 30950094
Tob Control. 2019 Sep;28(5):485-492
pubmed: 30068563
Rev Mal Respir. 2019 Jan;36(1):82-103
pubmed: 30429092
Nicotine Tob Res. 2016 Oct;18(10):1926-1936
pubmed: 27113014
CA Cancer J Clin. 2011 Mar-Apr;61(2):69-90
pubmed: 21296855
BMC Public Health. 2016 May 26;16:445
pubmed: 27229464
PLoS One. 2014 Jul 29;9(7):e103462
pubmed: 25072466
Am J Prev Med. 2017 Feb;52(2):e33-e66
pubmed: 27914771
Cochrane Database Syst Rev. 2014;(12):CD010216
pubmed: 25515689
Nicotine Tob Res. 2016 Oct;18(10):1937-1943
pubmed: 26783292
Tob Control. 2019 Jan;28(1):113-114
pubmed: 29374094
Int J Cancer. 2009 Jan 1;124(1):36-45
pubmed: 18844224
Alcohol Res. 2014;36(1):91-100
pubmed: 26259003
N Engl J Med. 2019 May 16;380(20):1973
pubmed: 31091382
Am J Prev Med. 2019 Jan;56(1):167-178
pubmed: 30573147
Tob Control. 2018 Nov;27(Suppl 1):s20-s25
pubmed: 30158203
Tob Control. 2018 Nov;27(Suppl 1):s1-s6
pubmed: 30352841
Crit Rev Oncol Hematol. 2019 Jun;138:139-147
pubmed: 31092369
Eur J Health Econ. 2019 Dec;20(9):1287-1301
pubmed: 31485831
Health Econ. 2010 Nov;19(11):1264-80
pubmed: 19816884
Int J Environ Res Public Health. 2011 Nov;8(11):4118-39
pubmed: 22163198
Addiction. 2019 Jun;114(6):1076-1085
pubmed: 30868688
J Thorac Dis. 2019 Dec;11(12):5572-5585
pubmed: 32030277
BMJ Open. 2017 Apr 1;7(4):e013079
pubmed: 28365587
Tob Induc Dis. 2018 Dec 17;16:A5
pubmed: 31516461
BMJ Open. 2017 Feb 23;7(2):e012680
pubmed: 28235965
Addiction. 2015 Jul;110(7):1160-8
pubmed: 25900312
Nicotine Tob Res. 2018 Sep 4;20(10):1272-1277
pubmed: 29065204
J Clin Oncol. 2015 Mar 10;33(8):952-63
pubmed: 25572671
Lancet. 2013 Jan 12;381(9861):133-41
pubmed: 23107252
PLoS One. 2015 Mar 30;10(3):e0122544
pubmed: 25822251
Nicotine Tob Res. 2015 Feb;17(2):127-33
pubmed: 25301815
N Engl J Med. 2019 Feb 14;380(7):629-637
pubmed: 30699054
Int J Environ Res Public Health. 2019 Sep 27;16(19):
pubmed: 31569603
Int J Behav Med. 2019 Dec;26(6):658-664
pubmed: 31741294
Health Econ. 2006 Dec;15(12):1283-94
pubmed: 16786502
ERJ Open Res. 2019 Feb 11;5(1):
pubmed: 30775377
Eur J Public Health. 2019 Feb 1;29(1):164-169
pubmed: 30010742
Health Econ. 2015 Nov;24(11):1502-16
pubmed: 25251559
Tob Control. 2016 Jan;25(1):60-5
pubmed: 25335901
Int J Environ Res Public Health. 2014 Oct 29;11(11):11220-48
pubmed: 25358095
BMJ Open. 2017 Dec 19;7(12):e016826
pubmed: 29259054
J Health Econ. 2004 Mar;23(2):293-311
pubmed: 15019756
Int J Public Health. 2016 Mar;61(2):257-67
pubmed: 26825455
Chem Res Toxicol. 2019 Jun 17;32(6):1289-1298
pubmed: 30932480
Nicotine Tob Res. 2019 Sep 19;:
pubmed: 31535686
Lancet Respir Med. 2016 Feb;4(2):116-28
pubmed: 26776875
JAMA Intern Med. 2014 May;174(5):812-3
pubmed: 24664434
J Policy Anal Manage. 2005 Fall;24(4):771-84
pubmed: 16201059
BMC Public Health. 2019 Jun 13;19(1):742
pubmed: 31196124

Auteurs

Daniela Bafunno (D)

Thoracic Oncology Unit, IRCCS Istituto Tumori "Giovanni Paolo II", Bari, Italy.

Annamaria Catino (A)

Thoracic Oncology Unit, IRCCS Istituto Tumori "Giovanni Paolo II", Bari, Italy.

Vito Lamorgese (V)

Thoracic Oncology Unit, IRCCS Istituto Tumori "Giovanni Paolo II", Bari, Italy.

Gabriella Del Bene (G)

Thoracic Oncology Unit, IRCCS Istituto Tumori "Giovanni Paolo II", Bari, Italy.

Vito Longo (V)

Thoracic Oncology Unit, IRCCS Istituto Tumori "Giovanni Paolo II", Bari, Italy.

Michele Montrone (M)

Thoracic Oncology Unit, IRCCS Istituto Tumori "Giovanni Paolo II", Bari, Italy.

Francesco Pesola (F)

Thoracic Oncology Unit, IRCCS Istituto Tumori "Giovanni Paolo II", Bari, Italy.

Pamela Pizzutilo (P)

Thoracic Oncology Unit, IRCCS Istituto Tumori "Giovanni Paolo II", Bari, Italy.

Sandro Cassiano (S)

Thoracic Oncology Unit, IRCCS Istituto Tumori "Giovanni Paolo II", Bari, Italy.

Angelica Mastrandrea (A)

Thoracic Oncology Unit, IRCCS Istituto Tumori "Giovanni Paolo II", Bari, Italy.

Donata Ricci (D)

Thoracic Oncology Unit, IRCCS Istituto Tumori "Giovanni Paolo II", Bari, Italy.

Patrizia Petrillo (P)

Thoracic Oncology Unit, IRCCS Istituto Tumori "Giovanni Paolo II", Bari, Italy.

Niccolò Varesano (N)

Thoracic Oncology Unit, IRCCS Istituto Tumori "Giovanni Paolo II", Bari, Italy.

Antonella Zacheo (A)

Thoracic Oncology Unit, IRCCS Istituto Tumori "Giovanni Paolo II", Bari, Italy.

Domenico Galetta (D)

Thoracic Oncology Unit, IRCCS Istituto Tumori "Giovanni Paolo II", Bari, Italy.

Classifications MeSH